Combined with the analysis of intestinal flora metabolomics and hepatic proteomics, PAPS1 was found to exert its inhibitory effect on the inflammatory response by modulating the NF-κB/STAT3 signaling pathway, thereby effectively ameliorating symptoms associated with HLP. This evidence concerns the gene NFKB1 and hyperkeratosis lenticularis perstans.